Deferoxamine, deferasirox, and deferiprone triple iron chelator combination therapy for transfusion-dependent β-thalassaemia with very high iron overload: a randomised clinical trial

Autor: Premawardhena, Anuja, Wanasinghe, Sakuni, Perera, Chamodi, Wijethilaka, Muditha Nayana, Rajakaruna, R.H.M.G., Samarasinghe, R.A.N.K.K., Williams, Senani, Mettananda, Sachith
Zdroj: In The Lancet Regional Health - Southeast Asia November 2024 30
Databáze: ScienceDirect